文献速递临床试验与 GCP流行病学与生物统计

EPO2CH项目预防择期腹部手术后手术部位感染的统计分析计划

Enhanced PeriOperative Care and Health protection programme for the prevention of surgical site infections after elective abdominal surgery (EPO2CH): statistical analysis plan of a randomised controlled multicentre superiority trial.
PubMed 文献 · Trials · 2021-04-21

EPO2CH是一项开放标签、实用型随机对照多中心优效性试验,旨在评估围手术期综合干预方案(EPO2CH集束化措施)联合标准护理能否降低择期腹部手术后手术部位感染(SSI)的发生率。本文描述该试验的统计分析计划,主要终点为术后30天内依据美国CDC标准定义的SSI发生率,采用意向性治疗分析,使用对数二项模型估计相对危险度。

要点

  • EPO2CH集束化措施包括术中高吸入氧浓度、目标导向液体治疗、主动保温、血糖控制及伤口冲洗。
  • 主要终点为术后30天内CDC定义的SSI发生率,采用意向性治疗分析。
  • 统计分析计划详细描述了主要分析、次要分析及不同干预措施归因效应的探索。

核心结论

  • EPO2CH试验的结果将确定该集束化方案能否有效预防择期腹部手术患者的SSI。

研究设计与样本

  • 开放标签、实用型随机对照平行组多中心优效性试验。
  • 主要终点为术后30天内CDC定义的SSI发生率,通过荷兰国家并发症登记和病历审查评估。
  • 主要分析采用意向性治疗原则,使用对数二项模型估计相对危险度,若不可行则用逻辑回归估计比值比。
  • 同时进行符合方案分析,并探索各独立干预措施的归因效应。

关键数值与推荐

  • 术中高吸入氧浓度;术中目标导向液体治疗;术前、术中、术后主动保温;血糖控制及治疗高血糖(>10 mmol/L),适用于糖尿病患者和非糖尿病患者;伤口闭合前使用水性抗菌剂冲洗。
  • 次要终点包括术后90天内SSI发生率、30天和90天吻合口漏发生率、1年内切口疝发生率、1年和5年死亡率、生活质量、健康与残疾状况以及成本效果。

临床怎么用

  • 若试验证明有效,EPO2CH集束化措施可整合至择期腹部手术的围手术期护理中,以降低SSI发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical site infections (SSI) are frequent complications after elective abdominal surgery. We designed the Enhanced PeriOperative Care and Health Protection programme (EPO2CH) care bundle, comprising of intraoperative high fractional inspired oxygen; intraoperative goal-directed fluid therapy; active preoperative, intraoperative and postoperative warming; glucose control and treatment of hyperglycaemia (> 10 mmol L- 1) in diabetics as well as non-diabetics; and wound irrigation before closure using an aqueous antiseptic. We hypothesise that EPO2CH added to standard care reduces the incidence of SSI compared to standard care alone for elective abdominal surgery. METHODS: This trial is designed as an open label, pragmatic randomised controlled parallel-group multicentre superiority trial. The primary endpoint is the incidence of SSI, defined by the Centers for Disease Control and prevention, within 30 days after surgery. The incidence of SSI is assessed using the Dutch national complication register and medical chart review. Secondary endpoints include the SSI incidence within 90 days, incidence of anastomotic leakage at 30 and 90 days, the incidence of incisional hernia within 1 year, mortality within 1 year and 5 years, quality of life, health and disability, and cost-effectiveness. Primarily, an intention-to-treat analysis will be performed to estimate the relative risk using a log binomial model. If not feasible, a logistic regression will be used to estimate the odds ratio. A per-protocol analysis will also be performed. Furthermore, the attributive effect of the distinct interventions will be explored. DISCUSSION: The results of the EPO2CH trial will determine if the EPO2CH bundle is effective to prevent SSI incidence for patients undergoing elective abdominal surgery. Details of the statistical analysis are described in this Statistical Analysis Plan (SAP). TRIAL REGISTRATION: Registration number: Dutch Trial Register Trial NL5572 . Registered on March 3, 2016. SAP version: V1.0, January 8, 2020. This SAP has been written based on study protocol V10.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. de Jonge SW, Wolfhagen N, Zwinderman AH, et al. Enhanced PeriOperative Care and Health protection programme for the prevention of surgical site infections after elective abdominal surgery (EPO2CH): statistical analysis plan of a randomised controlled multicentre superiority trial. Trials. 2021. PMID: 33883024. doi:10.1186/s13063-021-05202-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。